The relevance of pharmacology in clinical oncology practice
- 1 June 1993
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 4 (6) , 466-469
- https://doi.org/10.1093/oxfordjournals.annonc.a058554
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- ABC of monitoring drug therapy. Making the most of plasma drug concentration measurements.BMJ, 1993
- The impact of pharmacokinetically guided dose escalation strategies in phase I clinical trials: Critical evaluation and recommendations for future studiesAnnals of Oncology, 1992
- Pharmacokinetic Optimisation of Anticancer TherapyClinical Pharmacokinetics, 1991
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicinClinical Pharmacology & Therapeutics, 1989
- Adaptive control of etoposide administration: Impact of interpatient pharmacodynamic variabilityClinical Pharmacology & Therapeutics, 1989
- 5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancerBritish Journal of Cancer, 1989
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugsCancer Treatment Reviews, 1982
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977